How many Invex Therapeutics shares are in issue?
Invex Therapeutics has 75,153,848 shares in issue.
What is the market cap of Invex Therapeutics?
The market capitalisation of Invex Therapeutics is AUD 5.04 M.
What is the 1 year trading range for Invex Therapeutics share price?
Invex Therapeutics has traded in the range of AUD 0.06 to AUD 0.34 during the past year.
What is the PE ratio of Invex Therapeutics?
The price to earnings ratio of Invex Therapeutics is -3.21.
What is the cash to sales ratio of Invex Therapeutics?
The cash to sales ratio of Invex Therapeutics is 4.35.
What is the reporting currency for Invex Therapeutics?
Invex Therapeutics reports financial results in AUD.
What is the latest annual turnover for Invex Therapeutics?
The latest annual turnover of Invex Therapeutics is AUD 1.21M.
What is the latest annual profit for Invex Therapeutics?
The latest annual profit of Invex Therapeutics is AUD -1.64M.
What is the registered address of Invex Therapeutics?
The registered address for Invex Therapeutics is LEVEL 1, 38 ROWLAND STREET, SUBIACO, PERTH, WESTERN AUSTRALIA, 6008.
What is the Invex Therapeutics website address?
The website address for Invex Therapeutics is www.invextherapeutics.com.
Which industry sector does Invex Therapeutics operate in?
Invex Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector.
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
